C

Cyclacel Pharmaceuticals
D

CYCC

0.31800
USD
-0.01
(-4.04%)
Market Closed
Volume
0
EPS
-3
Div Yield
-
P/E
-0
Market Cap
1,999,331
OverviewSignalsIdeasNews
Related Instruments
    A
    ADMP
    0
    (0%)
    0.000000 USD
    A
    AVXL
    2.530
    (29.32%)
    11.160 USD
    C
    CLRB
    0.03490
    (14.73%)
    0.27180 USD
    C
    CTIC
    0.11000
    (2.54%)
    4.44000 USD
    D
    DCTH
    0.425
    (3.86%)
    11.430 USD
    I
    INFI
    -0.046100
    (-55.54%)
    0.036900 USD
    P
    PTN
    -0.01000
    (-1.04%)
    0.95000 USD
    S
    SLS
    0.01340
    (1.49%)
    0.91420 USD
    More
News

Title: Cyclacel Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.